FN1 and neoplasm: As shown in Figure 7, GM101 monotherapy led to significant suppression of major tumor ECM components (collagen I and fibronectin) compared to PBS, SBHA, or MS-275 monotherapy groups (P < 0.001), demonstrating the potent ECM degrading property of GM101 in tumor tissues.